製薬協加盟企業におけるトキシコゲノミックス（TG）及びファルマコゲノミクスゲノミス（PG）導入の現状（2005）

32nd Annual Meeting of the Japanese Society of Toxicology

Session ID : P-56

Conference information

Poster Presentation

Current status of pharmaceutical industries in Japan on pharmacogenomics and toxicogenomics in 2005

Author information

*Jun-ichi Kawahara
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Akiharu Inoue
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Takako Ohkura
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Shinichi Matsumoto
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Terutomo Kohira
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Shingo Nomoto
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Kounori Kotosai
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Takashi Unno
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Shinsaku Naito
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Fumio Sagami
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association

CONFERENCE PROCEEDINGS FREE ACCESS

Details